Literature DB >> 18581418

Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart.

John C Wood1, Michelle Aguilar, Maya Otto-Duessel, Hanspeter Nick, Marvin D Nelson, Rex Moats.   

Abstract

MRI is gaining increasing importance for the noninvasive quantification of organ iron burden. Since transverse relaxation rates depend on iron distribution as well as iron concentration, physiologic and pharmacologic processes that alter iron distribution could change MRI calibration curves. This article compares the effect of three iron chelators, deferoxamine, deferiprone, and deferasirox, on R1 and R2 calibration curves according to two iron loading and chelation strategies. Thirty-three Mongolian gerbils underwent iron loading (iron dextran 500 mg/kg/wk) for 3 weeks followed by 4 weeks of chelation. An additional 56 animals received less aggressive loading (200 mg/kg/week) for 10 weeks, followed by 12 weeks of chelation. R1 and R2 calibration curves were compared to results from 23 iron-loaded animals that had not received chelation. Acute iron loading and chelation-biased R1 and R2 from the unchelated reference calibration curves but chelator-specific changes were not observed, suggesting physiologic rather than pharmacologic differences in iron distribution. Long-term chelation deferiprone treatment increased liver R1 50% (P < 0.01), while long-term deferasirox lowered liver R2 30.9% (P < 0.0001). The relationship between R1 and R2 and organ iron concentration may depend on the acuity of iron loading and unloading as well as the iron chelator administered. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581418      PMCID: PMC2525452          DOI: 10.1002/mrm.21660

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Relaxation effects of clustered particles.

Authors:  A Tanimoto; K Oshio; M Suematsu; D Pouliquen; D D Stark
Journal:  J Magn Reson Imaging       Date:  2001-07       Impact factor: 4.813

3.  Relaxivities of human liver and spleen ferritin.

Authors:  Yves Gossuin; Robert N Muller; Pierre Gillis; Lionel Bartel
Journal:  Magn Reson Imaging       Date:  2005-12       Impact factor: 2.546

4.  Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo.

Authors:  Yves Gossuin; Pierre Gillis; Robert N Muller; Aline Hocq
Journal:  NMR Biomed       Date:  2007-12       Impact factor: 4.044

5.  ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.

Authors:  C Hershko; A M Konijn; H P Nick; W Breuer; Z I Cabantchik; G Link
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

6.  Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil.

Authors:  John C Wood; Maya Otto-Duessel; Ignacio Gonzalez; Michelle I Aguilar; Hiro Shimada; Hanspeter Nick; Marvin Nelson; Rex Moats
Journal:  Transl Res       Date:  2006-11       Impact factor: 7.012

7.  MRI detects myocardial iron in the human heart.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Ignacio Gonzalez; Marvin D Nelson; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

8.  Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens.

Authors:  Nilesh R Ghugre; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

9.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

10.  The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprone treatment.

Authors:  C Hershko; G Link; A M Konijn; M Huerta; E Rosenmann; C Reinus
Journal:  J Lab Clin Med       Date:  2002-01
View more
  5 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Authors:  Nilesh R Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland Fischer; Roger Williams; Paul Harmatz; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

3.  Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.

Authors:  Casey J Brewer; Thomas D Coates; John C Wood
Journal:  J Magn Reson Imaging       Date:  2009-02       Impact factor: 4.813

4.  The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease.

Authors:  J M Virtanen; K J Remes; M A Itälä-Remes; J P Saunavaara; M E Komu; A M Partanen; R K Parkkola
Journal:  Blood Cancer J       Date:  2012-01-13       Impact factor: 11.037

5.  Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration.

Authors:  Tim G St Pierre; Amal El-Beshlawy; Mohsen Elalfy; Abdullah Al Jefri; Kusai Al Zir; Shahina Daar; Dany Habr; Ulrike Kriemler-Krahn; Ali Taher
Journal:  Magn Reson Med       Date:  2013-07-02       Impact factor: 4.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.